Stocks of Pure Biologics Spólka Akcyjna - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | Pure Biologics Spólka Akcyjna |
| ompany Name: | Pure Biologics S.A. |
| Ticker: | PUR.WA |
| Exchange: | Warsaw |
| Outstanding stocks: | 3,327,810 |
| 24-hour Volume: | 8,869 |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Number of Employees: | 96 |
| Country: | Poland |
| City: | Wroclaw |
| Address: | ul. Dunska 11 |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| / | / | -11.1 PLN | / | 4.05 PLN | 29,417,840.00 PLN |
| P/E Ratio: | / |
|---|---|
| Forward P/E: | / |
| EPS: | -11.1 PLN |
| Forward EPS: | / |
| Book value per share: | 4.05 PLN |
| Market capitalization: | 29,417,840.00 PLN |
Pure Biologics Spólka Akcyjna
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 109,000.00 PLN |
| Net Income: | -31,716,000.00 PLN |
| Price-to-Book (P/B) Ratio: | 2.00 |
| PEG Ratio: | / |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for Pure Biologics Spólka Akcyjna stocks is: none |
| Number of Analysts: | Pure Biologics Spólka Akcyjna stocks are not covered by analysts. |
| Highest Target Price: | / |
| Lowest Target Price: | / |
| Average Target Price: | / |
Note: The data is approximate. Recommendations and price forecasts for Pure Biologics Spólka Akcyjna stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company Pure Biologics Spólka Akcyjna is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Pure Biologics Spólka Akcyjna Stocks?
If you're interested in investing in Pure Biologics Spólka Akcyjna stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Pure Biologics Spólka Akcyjna stocks through mobile apps with client support. In this table, you can compare brokers offering real Pure Biologics Spólka Akcyjna stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Pure Biologics Spólka Akcyjna (PUR.WA)
Revenues of 109,000.00 PLN indicate room for growth and improvement for Pure Biologics Spólka Akcyjna. This presents an opportunity for further development. Negative EBITDA of -26,701,000.00 PLN may indicate challenges but also opportunities for Pure Biologics Spólka Akcyjna to invest in future growth. A higher debt-to-equity ratio of 3.18 indicates higher leverage for Pure Biologics Spólka Akcyjna compared to its equity, requiring cautious management. Gross margin of 0.00% indicates room for Pure Biologics Spólka Akcyjna to improve cost efficiency and competitiveness. Lower profit margin of 0.00% suggests opportunities for Pure Biologics Spólka Akcyjna to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 109,000.00 PLN |
| EBITDA: | -26,701,000.00 PLN - Negative EBITDA may signal financial challenges or growth investments. |
| Earnings Per Share: | -11.1 PLN |
| Book Value Per Share: | 4.05 PLN |
| Total Cash: | 10,622,000.00 PLN |
| Total Cash per Share: | 3.31 PLN |
| Total Debt: | 41,359,000.00 PLN |
| Debt to Equity Ratio: | 3.18 |
| Quick Ratio: | 2.05 |
| Current Ratio: | 2.20 |
| Free Cash Flow: | -16,659,000.00 PLN |
| Operating Cash Flow: | -24,876,000.00 PLN |
| Company Margins | |
| Gross Margins: | / |
| EBITDA Margins: | / |
| Operating Margins: | -11,160.71 % |
| Profit Margins: | / |
| Performance | |
| Return on Assets: | -38.3 % |
| Return on Equity: | -169.8 % |
| Earnings Growth (1 year): | / |
| Revenue Growth (1 year): | -78.7 % |
| Year-over-Year Quarterly Earnings Growth: | / |
| Valuation | |
| Market Capitalization: | 29,417,840.00 PLN |
| Enterprise Value: | 56,770,400.00 PLN |
| EV/Revenue: | 520.829 |
| EV/EBITDA: | -2.126 |
| Number of Shares and Short Shares | |
| Float Shares: | 2,402,754 shares |
| Shares Outstanding: | 3,214,000 shares |
| Held Percent Insiders: | 0.14 % |
| Held Percent Institutions: | 6.57 % |
| Shares Short: | / |
| Shares Short Prior Month: | / |
| Date Short Interest: | / |
| Shares Percent Shares Out: | / |
| Short Ratio: | / |
| Beta: | 1.23 |
| Short Percent of Float: | / |
| Předpokládaný počet akcií: | 3,338,900 |
Frequently Asked Questions (FAQ)
According to our data, Pure Biologics Spólka Akcyjna does not currently pay dividends, even in 2024.
Pure Biologics Spólka Akcyjna shares are traded on the stock exchange Warsaw under the ticker symbol: PUR.WA. You can buy or trade them with a variety of stock brokers offering real stock trading services.
There has been no prediction or recommendation issued for Pure Biologics Spólka Akcyjna shares yet.
The total number of Pure Biologics Spólka Akcyjna shares on the exchange is 3,214,000.00, which, at the current market capitalization, values the company at 29,417,840.00 PLN.
